The Test-to-PrEP Study
Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information
2 other identifiers
interventional
320
1 country
1
Brief Summary
To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv-infections
Started Apr 2025
Typical duration for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2025
CompletedStudy Start
First participant enrolled
April 10, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
April 27, 2026
April 1, 2026
3.2 years
April 7, 2025
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Number of Alter participants per ego who use the HIV self-test kit
Number of Alter participants per ego who use an HIV self-test kit, indicated by completion of the Post-Test Survey.
Up to 6 months
Number of Alter participants per ego using an HIV self-test who meet criteria for PrEP
Number of Alter participants per ego using an HIV self-test who meet criteria for PrEP
Up to 6 months
Secondary Outcomes (2)
Number of Alters per ego initiating PrEP
Up to 6 months
Alters' self-reported PrEP knowledge as indicated by the Post-Test Survey.
Up to 6 months
Study Arms (2)
Test-to-PrEP group
EXPERIMENTALParticipants in this group will receive the Test-to-PrEP intervention for up to 1 year
Access by Referral group
EXPERIMENTALParticipants in this group will receive the Access by Referral intervention for up to 1 year
Interventions
Participants, called Egos, will come once to the clinic throughout the duration of the study, for up to 1 hour. During the visit, participants will receive up to 4 Test-to-PrEP Packs, which include an HIV self-test kit and HIV prevention education materials and a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Test-to-PrEP Packs to Social Network Contacts (peers), called Alters.
Participants, called Egos, will receive up to 4 Access by Referral Cards once. Participants will receive a brief (approximately 15 minutes) training. The training includes instructions on how to initiate conversations related to HIV, HIV testing, and HIV prevention, as well as proper handling of the HIV self-test kit. Participants are asked to distribute the Access by Referral Cards to Social Network Contacts (peers), also called Alters. The Referral Card can be used to order a Test-to-PrEP Pack, including the HIV self-test and HIV prevention education material, that will be mailed to an address of the Alter's choice.
Eligibility Criteria
You may qualify if:
- Stated willingness to provide informed consent.
- Stated willingness to comply with all study procedures.
- Stated availability for the duration of the study.
- Ability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
- Currently prescribed PrEP by RAPID clinics, including those initiating PrEP on the same day as study enrollment.
- \- Provision of electronic informed consent prior to completion of the Quick Response (QR)-linked survey instruments.
You may not qualify if:
- Inability or refusal to provide informed consent (e.g., cognitive impairment).
- Unable or unwilling to comply with study procedures per study investigator
- Inability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
- Aged 17 years or younger.
- Failure to provide electronic informed consent prior to starting QR-linked Alter survey tools.
- Age 17 years or younger.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanne Dobleck-Lewis, MD
University of Miami
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical Medicine
Study Record Dates
First Submitted
April 7, 2025
First Posted
April 15, 2025
Study Start
April 10, 2025
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share